IN BRIEF: Physiomics Annual Revenue Grows And Loss Narrows
IN BRIEF: Physiomics Annual Revenue Grows And Loss Narrows
Read moreFri, 31st Jul 2020 12:08
IN BRIEF: Physiomics Annual Revenue Grows And Loss Narrows
Read moreUK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic
Read moreIN BRIEF: Physiomics Has No Explanation For Share Price Surge
Read morePhysiomics Raises New Funds To "Further Develop Its Business"
Read more(Sharecast News) - Oncology consultancy Physiomics has raised roughly £829,000 through a share issue to finance further development.
Read morePhysiomics Secures Additional Contract With Bicycle Therapeutics
Read morePhysiomics Believes Strong Pipeline Can Withstand Covid-19 Oubtreak
Read more(Sharecast News) - Oncology consulting company Physiomics has received a 'Connect' award from the National Institute for Health Research's (NIHR) 'Invention for Innovation' (i4i) programme, for the continued development of its tool for use in the personalised treatment of cancer.
Read morePhysiomics Secures Contract Extension With Existing Client Merck
Read morePhysiomics First Half Revenue Rises But No Grants Means Widened Loss
Read more(Sharecast News) - Oncology consultancy Physiomics said on Tuesday that interim losses had widened despite posting an improvement in revenues.
Read morePhysiomics Signs Further Project Agreement With CellCentric
Read more(Sharecast News) - Oncology consultancy business Physiomics has been awarded a further project agreement with British biotech outfit CellCentric.
Read moreMerck Commits To Initial Contracts With Physiomics For 2020
Read more